About
Michael Kalos is a biopharma executive with 30 years of experience in cell therapy, immunooncology, and oncology vaccines. He currently serves as an independent board member at ImmunoScape and as founder and managing director of Next Pillar Consulting, while holding venture partner roles at Alloy Therapeutics and Orange Grove Bio. His career includes executive positions at ArsenalBio, Janssen, and Eli Lilly, as well as academic research at the University of Pennsylvania and City of Hope, where he contributed to the development of the CTL019 program underlying Kymriah; he holds a PhD from the University of Minnesota, has authored over 85 peer-reviewed publications, and holds 32 patents in cell therapy and immunotherapy.
Experience
- ImmunoScapeBoard of Directors, Independent Membercurrent2026 β presentSingapore
- Alloy Therapeutics, Inc.Executive Venture Partnercurrent2025 β presentPhiladelphia, Pennsylvania, United States
- Next Pillar Consulting, LLCFounder and Managing Directorcurrent2020 β presentPhiladelphia, PA
- IpiNovyx BioChief Executive Officer2024 β 2026Cincinnati, OH
- Orange Grove BioSenior Venture Partner2022 β 2026Philadelphia, PA
- Nanocell TherapeuticsBoard of Directors, Independent Member2021 β 2026Utrecht, Netherlands
- IMV Inc.Board of Directors, Independent Member. Member Compensation and Clinical subcommittees2021 β 2023Canada
- CTRL TherapeuticsFounding Chief Scientific Officer2022 β 2023Philadelphia, PA
- ArsenalBioExecutive Vice President and Head of R&D2019 β 2020South San Fransisco
- The Janssen Pharmaceutical Companies of Johnson & JohnsonVice President, Immunooncology and Oncology Cell Therapies2018 β 2019Greater Philadelphia Area
- Eli Lilly and CompanyChief Scientific Officer, Cancer Immunobiology, Distinguished Lilly Scholar2013 β 2018Greater New York City Area
- University of Pennsylvania School of MedicineAdjunct Associate Professor, Founding Director, Translational and Correlative Studies Laboratory2008 β 2013Philadelphia, PA
- City of HopeAssociate Professor, Founding Director of the Clinical Immunobiology Corrrelative Studies Laboratory2004 β 2008Duarte, California, United States
- Corixa CorporationSenior scientist1997 β 2004
- Fred Hutchinson Cancer Research CenterPostdoctoral fellow1990 β 1997
Education
- University of Minnesota Medical SchoolPhD, Microbiology1985 β 1990
- University of MinnesotaBS, Biochemistry1981 β 1983
Skills & more
+10 more
VirologyOncologyCancer ResearchBiochemistryClinical ResearchClinical DevelopmentLife SciencesClinical TrialsAssay DevelopmentGeneticsLanguages Greek
From Michael's professional profile.
Same school
Also attended University of Minnesota Medical School1
Also attended University of Minnesota82
+ 76 more
Shared employers
Also worked at ImmunoScape2
Also worked at Alloy Therapeutics, Inc.19
+ 13 more

























